Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CNSP

CNS Pharmaceuticals (CNSP)

CNS Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNSP
DateTimeSourceHeadlineSymbolCompany
11/19/20208:00AMPR Newswire (US)CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual MeetingNASDAQ:CNSPCNS Pharmaceuticals Inc
11/18/20208:00AMPR Newswire (US)CNS Pharmaceuticals to Participate in A.G.P.'s Virtual Healthcare SymposiumNASDAQ:CNSPCNS Pharmaceuticals Inc
11/12/20204:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
11/12/20208:00AMPR Newswire (US)CNS Pharmaceuticals to Discuss Phase 2 Clinical Trial Design to be Submitted for FDA Review in Webcast at 4:30 PM ET TodayNASDAQ:CNSPCNS Pharmaceuticals Inc
11/09/20208:00AMPR Newswire (US)CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA ReviewNASDAQ:CNSPCNS Pharmaceuticals Inc
10/29/20208:00AMPR Newswire (US)CNS Pharmaceuticals Completes Manufacturing of Berubicin for Phase 2 Clinical TrialNASDAQ:CNSPCNS Pharmaceuticals Inc
10/20/20208:00AMPR Newswire (US)CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin for Phase 2 Clinical TrialNASDAQ:CNSPCNS Pharmaceuticals Inc
10/12/20208:00AMPR Newswire (US)CNS Pharmaceuticals Highlights New Balancing Act Segment on Glioblastoma Airing on Lifetime TVNASDAQ:CNSPCNS Pharmaceuticals Inc
10/09/20208:00AMPR Newswire (US)CNS Pharmaceuticals Begins Manufacturing of Berubicin in EuropeNASDAQ:CNSPCNS Pharmaceuticals Inc
10/07/20205:01PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNSPCNS Pharmaceuticals Inc
10/01/20208:00AMPR Newswire (US)CNS Pharmaceuticals Achieves Critical Manufacturing MilestoneNASDAQ:CNSPCNS Pharmaceuticals Inc
09/25/20205:01PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/24/20208:00AMGlobeNewswire Inc.CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of BerubicinNASDAQ:CNSPCNS Pharmaceuticals Inc
09/24/20208:00AMPR Newswire (US)CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of BerubicinNASDAQ:CNSPCNS Pharmaceuticals Inc
09/21/20208:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/17/20208:00AMPR Newswire (US)CNS Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech SummitNASDAQ:CNSPCNS Pharmaceuticals Inc
09/16/20209:26AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/16/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/11/20208:00AMPR Newswire (US)CNS Pharmaceuticals to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment ConferenceNASDAQ:CNSPCNS Pharmaceuticals Inc
09/04/20204:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/03/20208:00AMGlobeNewswire Inc.CNS Pharmaceuticals Announces US Drug Manufacturing MilestonesNASDAQ:CNSPCNS Pharmaceuticals Inc
09/03/20208:00AMPR Newswire (US)CNS Pharmaceuticals Announces US Drug Manufacturing MilestonesNASDAQ:CNSPCNS Pharmaceuticals Inc
08/27/20208:00AMPR Newswire (US)CNS Pharmaceuticals Announces Appointment of Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Ins...NASDAQ:CNSPCNS Pharmaceuticals Inc
08/25/20207:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSPCNS Pharmaceuticals Inc
08/25/20208:39AMPR Newswire (US)CNS Provides FDA Update on IND FilingNASDAQ:CNSPCNS Pharmaceuticals Inc
08/20/20208:00AMPR Newswire (US)CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical TrialsNASDAQ:CNSPCNS Pharmaceuticals Inc
08/11/20208:00AMPR Newswire (US)CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020NASDAQ:CNSPCNS Pharmaceuticals Inc
08/10/20204:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSPCNS Pharmaceuticals Inc
07/22/20208:52AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSPCNS Pharmaceuticals Inc
07/22/20208:00AMPR Newswire (US)CNS Pharmaceuticals Recognizes Glioblastoma Awareness DayNASDAQ:CNSPCNS Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNSP